Stephanie F Ling (Stephanie Ling, S F Ling)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Venues

Pharmaceutics

Expert review of clinical immunology

Nutrients

The pharmacogenomics journal

University of Manchester

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Manchester

United Kingdom

Clinical Research Fellow :: Centre for Musculoskeletal Research

University of Manchester

United Kingdom

Academic clinical fellow :: Centre for Musculoskeletal Research

University Hospital Aintree

United Kingdom

Academic foundation trainee

Publications

Stephanie F Ling, Kayode Ogungbenro, Adam S Darwich, Amirah Binti Mohammad Ariff, Nisha Nair, James Bluett, Ann W Morgan, John D Isaacs, Anthony G Wilson, Kimme L Hyrich, Richard B Warren, Darren Plant
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis. Pharmaceutics 16 (6) (2024)
Stephanie F Ling, Kayode Ogungbenro, Adam S Darwich, Amirah Binti Mohammad Ariff, Nisha Nair, James Bluett, Ann W Morgan, John D Isaacs, Anthony G Wilson, Kimme L Hyrich, Richard B Warren, Darren Plant
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis. Pharmaceutics 16 (6) (2024)
Edward B Jude, Nikolaos Tentolouris, Pankaj Malhotra, Moi Hoon Yap, Hermelinda Cordeiro Pedrosa, Stephanie F Ling
Vitamin D prescribing practices among clinical practitioners during the COVID-19 pandemic. Health science reports 5 (4) (2022)
Stephanie F Ling, Eleanor Broad, Rebecca Murphy, Joseph M Pappachan, Satveer Pardesi-Newton, Marie-France Kong, Edward B Jude
High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study. Nutrients 12 (12) (2020)
Stephanie F Ling, Nisha Nair, Suzanne M M Verstappen, Richard B Warren, Hans-Dieter Zucht, Petra Budde, Peter Schulz-Knappe, null null, Darren Plant
Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients. The pharmacogenomics journal 20 (3) (2019)
Stephanie F Ling, James Bluett, Richard B Warren
Prediction of response to methotrexate in rheumatoid arthritis. Expert review of clinical immunology 14 (5) (2018)
T David, Stephanie F Ling, Richard B Warren
Genetics of immune-mediated inflammatory diseases. Clinical and experimental immunology 193 (1) (2018)

Stephanie F Ling.css-eqlu8i{font-size:small;padding-left:4px;} (Stephanie Ling, S F Ling)

Publication Activity (10 Years)

Top Topics

Top Venues

Stephanie F Ling (Stephanie Ling, S F Ling)